Newsroom

Mayo Clinic Laboratories now offers the first preeclampsia-specific test (Mayo ID: PERA) that can be used to stratify patients into low or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe features. With this information, clinicians can make more informed decisions about hospitalization, monitoring, more frequent checkups, and even early delivery.

Globally, five million deaths are associated with bacterial antimicrobial resistance each year, but the complexity of the issue is there is no single solution because we need to use antibiotics. It’s about finding a different way to live with it.

Mayo Clinic Laboratories is grateful for the opportunity to serve you and other healthcare professionals around the globe in providing critical answers and actionable insights.

Mayo Clinic Laboratories, a leading global reference laboratory, and Progentec Diagnostics, a digital health and biomarker technology-based company focused on autoimmune conditions, today announced a strategic collaboration to bring Progentec’s suite of proprietary biomarker blood tests for the proactive management of autoimmune diseases to market. The collaboration aims to increase accessibility for providers and patients across the U.S. and select global markets.

Top highlights include: Government to launch $300M Azlheimer's research database, new COVID variant XBB.1.16 spotted in 18 US states, and novel treatment shows promise against rare cancer in kids.

Today's Highlights Include: US FDA seeks to allow salt substitutes in everyday foods, radioactive water leaks at Minn. nuclear plant for 2nd time, and pushback grows over mental health impacts of social media.

In a post on Mayo Clinic’s News Network, Mayo Clinic’s director of Clinical Virology, Matthew Binnicker, Ph.D., explains the concern over a potential human-to-human outbreak of avian influenza and what’s being done at Mayo Clinic and elsewhere to mitigate that risk.

Today's Highlights Include: CDC adds COVID vaccine to routine immunization schedule for kids and adults, Governments target medical debt with COVID relief funds and Minnesota being the 1st state to screen all newborns for serious viral infection.

Today's Highlights Include: USDA proposes new nutrition standards for school meals, virtual care system designed for COVID-19 grows into a multiuse digital health tool, and Mayo Clinic explores use of artificial intelligence. Is It Hype Or Help?

Are you planning to attend Medlab Middle East 2023? If so, make an appointment to stop by Mayo Clinic Laboratories’ booth Z3.A30 to learn more about our comprehensive menu of advanced diagnostic testing.

Topic highlights include: FDA considers major shift in COVID vaccine strategy, DNA from blood samples could help early cancer detection, Wisconsin researchers say, CDC informs staff of reorganization after pandemic criticisms

The New England Journal of Medicine recently published new findings on periprosthetic joint infection by Dr. Robin Patel.

Topic highlights include: Phoenix Children’s opens specialty clinic at Avondale campus, Moderna says RSV vaccine is effective in older adults, WHO questions severity of XBB.1.5 COVID subvariant as U.S. cases rise